Clinical Trials Browser

Unknown × Leukemia, Myeloid × Clear all

NCT04965649 2023-08-30

TIPHI

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid

NCT04265963 2023-04-18

CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT04272125 2023-04-18

Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT05787951 2023-03-28

Frequency and Risk Factors of Acute Myeloid Leukemia

Other hematologic neoplasm

Leukemia, Myeloid

NCT04272957 2020-06-16

A Study of HMPL-306 in Patients With IDH1 and/or IDH2 Mutation of Relapsed/Refractory Myeloid Leukemia/Neoplasms

Phase 1 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Neoplasms, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT03417427 2020-04-27

A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML

Phase 2 Unknown

Other hematologic neoplasm

Pathologic Complete Response, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT03600558 2020-04-24

Efficacy of FLAG Regimen for the Treatment of Patients With AML

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT03638206 2019-12-11

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Phase 1/2 Unknown

CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

NCT03659084 2018-09-06

GREFFE

MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02333838 2018-08-13

TBF-Cord

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid

NCT03114670 2017-06-14

Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT

Phase 1 Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Neoplasms by Histologic Type, Recurrence, Leukemia, Myeloid, Acute, Disease Attributes

NCT03080922 2017-04-04

High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Recurrence, Leukemia, Myeloid, Acute

NCT01864902 2016-01-28

CART33

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid

NCT02489929 2015-07-03

Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine

Phase NA Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Myelodysplastic Syndromes

NCT01503502 2013-04-10

A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00111345 2012-05-23

Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents

Phase 2/3 Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT01066338 2010-02-19

Genome-wide Pharmacogenetic Candidate Gene Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Myeloid Leukemia With Normal Karyotype

Other hematologic neoplasm

Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT01066286 2010-02-10

Genome Wide SNP Array-based Approach to Detect Micro-cytogenetic Lesions and KIT Mutation to Improve Treatment Outcomes in Patients With Core-binding Factor Positive Acute Myeloid Leukemia

Other hematologic neoplasm

Leukemia, Myeloid, Leukemia, Myeloid, Acute